Gains at the 1p36 chromosomal region are associated with symptomatic leptomeningeal dissemination of supratentorial glioblastomas

被引:20
|
作者
Korshunov, Andrey
Sycheva, Regina
Golanov, Andrey
Pronin, Igor
机构
[1] Burdenko Neurosurg Inst, Dept Neuropathol, Moscow 125047, Russia
[2] Burdenko Neurosurg Inst, Dept Neurooncol Surg, Moscow, Russia
[3] Burdenko Neurosurg Inst, Dept Neuroroentgenol & Neuroradiol, Moscow, Russia
关键词
glioblastoma; dissemination; molecular analysis; 1p36; locus;
D O I
10.1309/DE4LNX3YMACCC1ER
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Symptomatic craniospinal dissemination of glioblastomas is considered rare, and unambiguous pathologic or molecular predictors of tumor leptomeningeal spread remain to be defined. We performed molecular analysis of 8 glioblastomas with symptomatic leptomeningeal dissemination by using fluorescence in situ hybridization and array-based comparative genomic hybridization (array-CGH). The most frequently encountered alteration was gain of the 1p36 locus, which was found in all 8 samples examined. Array-CGH analysis of 3 available samples also disclosed numerous gains at the 1pter-p36.1 locus involving at least 3 DNA clones from this chromosomal region. Consequently, an analysis of 1p copy number status might be kept in mind as an additional tool for further predicting the clinical course of glioblastoma.
引用
收藏
页码:585 / 590
页数:6
相关论文
共 50 条
  • [41] Mapping of a minimal deleted region on 1p36 in endocrine tumors of the parathyroid and adrenal medulla
    Carling, T
    Fang, W
    Correa, P
    Huang, S
    CYTOGENETICS AND CELL GENETICS, 2001, 92 (1-2): : 43 - 43
  • [42] CHROMOSOMAL ASSIGNMENT OF A GLUTAMIC-ACID TRANSFER-RNA (TRANSFER RNAGLU) GENE TO 1P36
    BOYD, E
    THERIAULT, A
    GODDARD, JP
    KALAITSIDAKI, M
    SPATHAS, DH
    CONNOR, JM
    HUMAN GENETICS, 1989, 81 (02) : 153 - 156
  • [43] FISH analysis of 26 patients with hematological neoplasias and 1p36 rearrangements allows to define a cluster of 2.5 Mb included in the minimal region deleted in the 1p36 deletion syndrome.
    Odero, MD
    Lahortiga, I
    Vazquez, I
    Roman, JP
    Belloni, E
    Agirre, X
    Valganon, M
    Pelicci, PG
    Hernandez, JM
    Calasanz, MJ
    BLOOD, 2003, 102 (11) : 222B - 222B
  • [44] Molecular characterization of a 1p36 chromosomal duplication and in utero interference define ENO1 as a candidate gene for polymicrogyria
    El Waly, Bilal
    Mignon-Ravix, Cecile
    Cacciagli, Pierre
    Buhler, Emmanuelle
    ben Zeev, Bruria
    Villard, Laurent
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (12) : 1703 - 1713
  • [45] 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
    Markus Mayrhofer
    Hanna Göransson Kultima
    Helgi Birgisson
    Magnus Sundström
    Lucy Mathot
    Karolina Edlund
    Björn Viklund
    Tobias Sjöblom
    Johan Botling
    Patrick Micke
    Lars Påhlman
    Bengt Glimelius
    Anders Isaksson
    BMC Cancer, 14
  • [46] 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
    Mayrhofer, Markus
    Kultima, Hanna Goransson
    Birgisson, Helgi
    Sundstrom, Magnus
    Mathot, Lucy
    Edlund, Karolina
    Viklund, Bjorn
    Sjoblom, Tobias
    Botling, Johan
    Micke, Patrick
    Pahlman, Lars
    Glimelius, Bengt
    Isaksson, Anders
    BMC CANCER, 2014, 14
  • [47] Molecular characterization of a 1p36 chromosomal duplication and in utero interference define ENO1 as a candidate gene for polymicrogyria
    Bilal El Waly
    Cécile Mignon-Ravix
    Pierre Cacciagli
    Emmanuelle Buhler
    Bruria ben Zeev
    Laurent Villard
    European Journal of Human Genetics, 2020, 28 : 1703 - 1713
  • [48] 1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors
    Tadeo, Irene
    Gamero-Sandemetrio, Esther
    Berbegall, Ana P.
    Navarro, Samuel
    Canete, Adela
    Noguera, Rosa
    HISTOLOGY AND HISTOPATHOLOGY, 2018, 33 (05) : 487 - 495
  • [49] A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer
    Heijmans, BT
    Boer, JMA
    Suchiman, HED
    Cornelisse, CJ
    Westendorp, RGJ
    Kromhout, D
    Feskens, EJM
    Slagboom, PE
    CANCER RESEARCH, 2003, 63 (06) : 1249 - 1253
  • [50] CHRONIC MYELOMONOCYTIC LEUKEMIA WITH CHROMOSOMAL CHANGES INVOLVING 1P36 AND HEPATOCELLULAR-CARCINOMA IN A CASE OF FANCONIS ANEMIA
    BESSHO, F
    MIZUTANI, S
    HAYASHI, Y
    MORIWAKI, K
    YOKOTA, S
    INABA, T
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 42 (05) : 492 - 495